Overview
Microspherophakia-metaphyseal dysplasia syndrome (also known as metaphyseal dysplasia with microspherophakia) is an extremely rare genetic disorder characterized by the combination of ocular abnormalities and skeletal anomalies. The condition primarily affects the eyes and the skeletal system. Microspherophakia refers to a small, spherically shaped lens of the eye, which can lead to significant visual problems including severe myopia (nearsightedness), lens subluxation (partial dislocation of the lens), and secondary glaucoma due to pupillary block. The skeletal component involves metaphyseal dysplasia, which is an abnormality in the growth regions (metaphyses) of long bones, potentially leading to short stature and characteristic radiographic findings in the limbs. The condition has been described in only a small number of families in the medical literature. Affected individuals may present in childhood with visual difficulties and skeletal abnormalities that become apparent on radiographic evaluation. Additional features that have been reported include brachydactyly (short fingers) and joint stiffness. Management is primarily symptomatic and supportive. Ophthalmologic care is essential and may include corrective lenses, monitoring for glaucoma, and surgical intervention if lens subluxation or glaucoma becomes problematic. Orthopedic follow-up may be needed to monitor skeletal growth and development. There is currently no specific curative treatment for this syndrome, and care focuses on addressing individual symptoms as they arise.
Also known as:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Microspherophakia-metaphyseal dysplasia syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Microspherophakia-metaphyseal dysplasia syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Microspherophakia-metaphyseal dysplasia syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Microspherophakia-metaphyseal dysplasia syndrome.
Community
No community posts yet. Be the first to share your experience with Microspherophakia-metaphyseal dysplasia syndrome.
Start the conversation →Latest news about Microspherophakia-metaphyseal dysplasia syndrome
No recent news articles for Microspherophakia-metaphyseal dysplasia syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Microspherophakia-metaphyseal dysplasia syndrome
What is Microspherophakia-metaphyseal dysplasia syndrome?
Microspherophakia-metaphyseal dysplasia syndrome (also known as metaphyseal dysplasia with microspherophakia) is an extremely rare genetic disorder characterized by the combination of ocular abnormalities and skeletal anomalies. The condition primarily affects the eyes and the skeletal system. Microspherophakia refers to a small, spherically shaped lens of the eye, which can lead to significant visual problems including severe myopia (nearsightedness), lens subluxation (partial dislocation of the lens), and secondary glaucoma due to pupillary block. The skeletal component involves metaphyseal
How is Microspherophakia-metaphyseal dysplasia syndrome inherited?
Microspherophakia-metaphyseal dysplasia syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Microspherophakia-metaphyseal dysplasia syndrome typically begin?
Typical onset of Microspherophakia-metaphyseal dysplasia syndrome is childhood. Age of onset can vary across affected individuals.